Skip to main content
Bivictrix Therapeutics Limited

Bivictrix Therapeutics Limited

Developing The Next Generation of Precision ADCs

https://beta.companieshouse.gov.uk/company/10005270

Tax Relief: SEIS EIS
Invest in Bivictrix Therapeutics Limited
105% Complete
105%
Funded
£430,000
Target
£451,506
Pledged

Summary

BiVictriX Therapeutics Ltd (“BiVictriX”) is a pharmaceutical company focused on developing and licensing novel Antibody Drug Conjugates (“ADCs”), which have been coined as the new ‘Magic Bullet’ therapeutics in the field of oncology. The Company has invented a novel strategy, ‘The Dual Targeting Approach’ that improves ADC selectivity towards cancer cells. The lead and back-up candidate are in the areas of Acute Myeloid Leukaemia (“AML”) and a specific type of Non-Hodgkin Lymphoma. These areas have been targeted due to a combination of unmet clinical need, market size, competition in the field and the specificity of the targeted antigens. The Company is seeking £430k of seed investment to commence operations and grow the Company through the engineering and production of materials to test in pivotal biological assays. Having developed its technology platform over the previous two years, the Company is expected to commence operations in August 2016. 


You need to be registered as an investor to see further information.


Join Now

None of the information contained here or contained outside of the InvestingZone platform, including on the pitching company’s own website, in social media profiles and elsewhere constitutes part of the listing and it has not been reviewed or approved by InvestingZone or by Acceleris Capital.

You need to be registered as an investor to see further information.


Join Now

None of the information contained here or contained outside of the InvestingZone platform, including on the pitching company’s own website, in social media profiles and elsewhere constitutes part of the listing and it has not been reviewed or approved by InvestingZone or by Acceleris Capital.

You need to be registered as an investor to see further information.


Join Now

None of the information contained here or contained outside of the InvestingZone platform, including on the pitching company’s own website, in social media profiles and elsewhere constitutes part of the listing and it has not been reviewed or approved by InvestingZone or by Acceleris Capital.

You need to be registered as an investor to see further information.


Join Now

None of the information contained here or contained outside of the InvestingZone platform, including on the pitching company’s own website, in social media profiles and elsewhere constitutes part of the listing and it has not been reviewed or approved by InvestingZone or by Acceleris Capital.

You need to be registered as an investor to see further information.


Join Now

None of the information contained here or contained outside of the InvestingZone platform, including on the pitching company’s own website, in social media profiles and elsewhere constitutes part of the listing and it has not been reviewed or approved by InvestingZone or by Acceleris Capital.

You need to be registered as an investor to see further information.


Join Now

Additional information

  • Seed
  • Technology
  • Electronic & Electrical Equipment